FB
Fortress Biotech, Inc.
FBIO · NASDAQ
$2.46 -0.81% (-$0.02)
1M -15.46%
Market Cap $81.7M
P/E Ratio 0.73x
Div. Yield -
ROE 103.52%
Piotroski F-Score Moderate
6/9Valuation
100 /100
Cheap P/E 0.73x
P/S 1.19x
P/B 0.50x
Growth
13 /100
Declining Rev. growth 5.83%
Book val. growth 6.13%
EPS growth N/A
Profitability
70 /100
Strong Gross margin 62.53%
Net margin 163.32%
Op. margin 42.86%
Quality
48 /100
Average ROIC 10.85%
ROE 103.52%
ROA 35.31%
Debt
98 /100
Low Debt/Equity 0.39x
Current ratio 3.96x
Int. coverage 17.26x
Stability
53 /100
Moderate Beta 1.19x
Rev. volatility 24.49%
EPS volatility 27.87%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about FBIO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Lindsay A. Rosenwald
Employees
78
Headquarters
Bay Harbor Islands
Upcoming events
16 NOV
Earnings
Upcoming earnings report